Примери за използване на Coronary intervention на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Patients underwent percutaneous coronary intervention receiving antithrombotic support with blinded study drug.
found to be linear in patients undergoing Percutaneous Coronary Intervention and in patients with ACS.
In Table 5 the efficacy results of patients undergoing percutaneous coronary intervention(PCI) are presented.
patients undergoing percutaneous coronary intervention.
For patients undergoing percutaneous coronary intervention, if the last subcutaneous injection of Clexane was performed less than 8 hours prior to inflation of the balloon catheter introduced at the site of the narrowing of the coronary artery, no additional solution is required.
If the patient undergoes a percutaneous coronary intervention(PCI or angioplasty,
in patients with acute coronary syndrome who are undergoing percutaneous coronary intervention.
in patients with acute coronary syndrome who are undergoing percutaneous coronary intervention.
who are undergoing percutaneous coronary intervention(PCI- a surgical procedure used to unblock narrowed blood vessels that supply the heart).
in patients who underwent percutaneous coronary intervention within 30 days after randomization(23 percent reduction in relative risk)
In patients with coronary heart disease after percutaneous coronary interventions the appropriate daily dose is 80 mg.
Secondary prevention of major adverse cardiac events in adults with coronary heart disease after percutaneous coronary interventions(see section 5.1).
Secondary prevention of major adverse cardiac events in adults with coronary heart disease after percutaneous coronary interventions(see section 5.1).'.
For patients with coronary heart disease after percutaneous coronary interventions, the CHMP agreed that the recommended daily dose is 80 mg.
Bypass surgery, percutaneous coronary interventions, or medicines may be needed to reduce the risk of another heart attack.
In patients with coronary heart disease after percutaneous coronary interventions the appropriate daily dose is 80 mg.'.
After three successful events we have planned even more interesting program for the upcoming 2015 Bulgarian Bifurcation and Complex Coronary Interventions Course.
It offered broad range of sessions related to bifurcations and complex coronary interventions, covering from essentials to the latest controversies in the field.
For coronary intervention see section 4.4.
What are the complications of percutaneous coronary intervention?